| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| PERSHING - SHORT TERM | 2022-04 | PURCHASE | 2023-01 | 1,691 | 1,685 | 6 | ||||
| PERSHING - LONG TERM | 2015-12 | PURCHASE | 2023-01 | 39,256 | 40,613 | -1,357 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| VANGUARD 500 INDEX FUND | AT COST | 15,377 | 58,363 |
| VANGUARD MID-CAP INV | AT COST | 34,361 | 85,857 |
| SHORT TERM INV GR- INV | AT COST | 100,049 | 93,795 |
| ISHARES S&P | AT COST | 120,055 | 150,453 |
| VANGUARD ST INV GR | AT COST | 24,891 | 23,200 |
| FIDELTY SELECT | AT COST | ||
| POLLEN GROWTH FUND | AT COST | ||
| APPLE | AT COST | 118 | 31,767 |
| FIDELITY SELECT HEALTH CARE | AT COST | 35,006 | 35,771 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 350 | |||
| OTHER FEES |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAX | 227 |